ARCHIVES

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

This article is from The Cancer Letter archive.

Vol. 13 No. 04 | January 23, 1987

Download PDF Visit The Full Archive

Related Articles

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000